Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q
Reporting Period: Quarter and nine months ended September 30, 1999
Business Overview: The Company operates two reportable segments: Lab Support (temporary/permanent placement of laboratory and scientific professionals) and Healthcare Financial Staffing (placement of medical billing and collection professionals). The Company also maintains an EnviroStaff division, which is transitioning away from remediation business.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1999 |
Nine Months Ended Sep 30, 1999 |
Balance Sheet Sep 30, 1999 |
|---|---|---|---|
| Revenues | $42,227,000 | $116,288,000 | - |
| Net Income | $3,783,000 | $10,296,000 | - |
| Diluted EPS | $0.34 | $0.92 | - |
| Gross Margin | 32.6% | 32.5% | - |
| Operating Margin | 13.3% | 13.0% | - |
| Cash & Equivalents | - | - | $24,345,000 |
| Marketable Securities | - | - | $14,810,000 |
| Total Current Liabilities | - | - | $8,846,000 |
| Long-Term Debt | - | - | $0 |
Note: The Company terminated its $7,000,000 unsecured bank line of credit on July 1, 1999. No long-term debt is reported on the balance sheet.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 18.8% for the quarter and 20.4% for the nine months compared to the prior year periods. Growth was driven by both the Healthcare Financial Staffing and Lab Support segments.
- Profitability: Net income rose 27.7% for the quarter and 28.6% for the nine months. Operating income increased 27.9% (quarter) and 28.4% (nine months).
- Cost Efficiency: Cost of services as a percentage of revenue decreased slightly (from 68.1% to 67.4% in the quarter; 68.5% to 67.5% in the nine months) due to lower unemployment insurance and workers' compensation expenses.
- Operating Expenses: Operating expenses increased 17.4% (quarter) and 21.4% (nine months), primarily due to investments in Account Manager training, recruiting, and international expansion (Canada and U.K.).
- Segment Performance: Healthcare Financial Staffing revenues grew significantly (74.2% increase for the nine months), while the EnviroStaff division saw a planned decline in remediation assignments.
Guidance, Outlook, and Risks
- Capital Allocation: The Board authorized a $15,000,000 stock repurchase program in April 1999. As of September 30, 1999, the Company had repurchased 205,000 shares for $4,804,000.
- Liquidity: Management believes cash balances and funds from operations are sufficient to meet requirements for the next twelve months. The Company has no outstanding bank line of credit.
- Year 2000 Readiness: The Company is approximately 90% complete with modifying/upgrading hardware and software. While no material costs are anticipated, risks remain regarding potential system failures or vendor/client issues that could disrupt operations.
- Acquisitions: The Company paid an additional $360,000 in contingent consideration for the 1998 acquisition of LabStaffers, Inc. Additional consideration up to $480,000 may be paid contingent on future revenue targets.
- Forward-Looking Risks: Risks include the ability to attract and retain qualified staff, integration of acquired operations, and expansion into new international markets.
Investor Verification Checklist
- Stock Repurchase Activity: Verify the remaining balance of the $15M repurchase authorization and future buyback plans.
- Year 2000 Compliance: Confirm the completion status of Phase 3 (modifications) and the testing of contingency plans to ensure no operational disruption.
- Segment Mix: Monitor the continued decline of the EnviroStaff remediation business versus the growth of the Healthcare Financial Staffing segment.
- Contingent Acquisition Costs: Track the revenue targets for the LabStaffers acquisition to determine if the remaining $480,000 contingent payment will be triggered.
- Debt Capacity: Assess the impact of terminating the $7M line of credit on future liquidity and expansion capabilities.